VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Impressive data: zanubrutinib for Waldenström’s macroglobulinemia

Judith Trotman, MBChB, FRACP, FRCPA, of the University of Sydney School of Medicine, Sydney, Australia, discusses exciting data in the use of zanubrutinib for Waldenström’s macroglobulinemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter